A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

NCT03316300 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Telangiectasia Type 2 (MacTel)

Interventions

COMBINATION_PRODUCT: NT-501
PROCEDURE: Sham Procedure

Sponsor

Neurotech Pharmaceuticals

Collaborators

[object Object]